Rigel Pharmaceuticals
RIGL
RIGL
122 hedge funds and large institutions have $203M invested in Rigel Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 43 increasing their positions, 19 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
5% more capital invested
Capital invested by funds: $193M → $203M (+$10.4M)
0.94% more ownership
Funds ownership: 67.65% → 68.59% (+0.94%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
122
Holding in Top 10
1
Calls
$1.28M
Puts
$34K
Top Buyers
| 1 | +$3.29M | |
| 2 | +$3.14M | |
| 3 | +$2.65M | |
| 4 |
JPMorgan Chase & Co
New York
|
+$2.59M |
| 5 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$2.55M |
Top Sellers
| 1 | -$17M | |
| 2 | -$6.46M | |
| 3 | -$5M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
-$2.23M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.55M |